Showing results (341-350 of 486) with videos related to
Sort By:
Pageof 49
Oncoimmunology|May 6, 2015
Trial watch: IDO inhibitors in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.Oncoimmunology|October 25, 2019
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patientsMaria Esperanza Rodriguez-Ruiz, Aitziber Buqué, Michal Hensler, et al.Oncoimmunology|November 22, 2012
Trial watch: Dendritic cell-based interventions for cancer therapyLorenzo Galluzzi, Laura Senovilla, Erika Vacchelli, et al.Autophagy|February 26, 2015
Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acidsMireia Niso-Santano, José Manuel Bravo-San Pedro, Maria Chiara Maiuri, et al.Seminars in Cancer Biology|March 10, 2015
eIF2α phosphorylation as a biomarker of immunogenic cell deathOliver Kepp, Michaela Semeraro, José Manuel Bravo-San Pedro, et al.Oncoimmunology|July 23, 2014
Trial Watch: Adoptive cell transfer for anticancer immunotherapyFernando Aranda, Erika Vacchelli, Florine Obrist, et al.Cell Cycle (Georgetown, Tex.)|August 6, 2010
Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cellsIlio Vitale, Mohamed Jemaà, Laura Senovilla, et al.Oncoimmunology|July 3, 2015
Trial Watch: Peptide-based anticancer vaccinesJonathan Pol, Norma Bloy, Aitziber Buqué, et al.Oncoimmunology|August 19, 2021
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cellsTakahiro Yamazaki, Erik Wennerberg, Michal Hensler, et al.Oncoimmunology|December 25, 2012
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effectsOliver Kepp, Laurie Menger, Erika Vacchelli, et al.Pageof 49